About Us
We are the commercialization partner of choice for innovative pharmaceutical and biotech companies seeking strong business growth in Central and Eastern Europe.
Our mission is to make the most advanced and effective medical treatments available to every patient in the region by leveraging our marketing know-how, scientific expertise and product knowledge.
As a partner to leading global pharmaceutical and biotech companies, we have been bringing innovative specialty pharmaceuticals, orphan drugs, advanced medical technologies and consumer health products to the CEE region for more than 35 years.
Founded in 1989, Medis employs more than 400 experts and specializes in the commercialization of innovative pharmaceuticals, with a focus on specialty medicines, medical devices and self-care brands.
Medis' wholly-owned subsidiaries operate in 19 countries in Europe. We are expanding our revenues at double-digit growth rates. By the end of 2025, we reached sales of € 182.2 million.
In total, Medis effectively covers a region with almost 140 million potential customers. Our significant medical, legal and cultural expertise across the region gives us a unique advantage in helping our partners achieve their strategic goals.
We strongly believe that all patients should have access to advanced medical treatments. Only then do innovations become truly valuable. That is why we are committed to providing innovative therapeutic options to patients in Central and Eastern Europe and improving their quality of life, while nurturing existing partnerships and building new ones. Maja Strnad Cestar Chief Executive Officer
MISSION
As a pharmaceutical company we strive to improve people’s health by providing innovative therapeutic solutions.
VISION
To be the commercialization partner of choice for innovative pharmaceutical companies to achieve strong business growth in Central and Eastern Europe.
Healthy Values
Life is simple when we are true to ourselves and to healthy values. We live and work hard for our values: